Skip to content

Postoperative Atrial Fibrillation and Long-term Survival

Postoperative Atrial Fibrillation After Cardiac Surgery is Not an Independent Risk Factor for Long-term Cardiovascular Morbidity and Mortality in Anticoagulated Patients

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02349269
Acronym
POAF
Enrollment
519
Registered
2015-01-28
Start date
2012-01-31
Completion date
2014-09-30
Last updated
2015-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Death, Myocardial Infarction, Stroke

Keywords

Atrial fibrillation, CABG, Stroke

Brief summary

The aim of the investigators trial was to evaluate association between new onset postoperative atrial fibrillation (POAF) and late cardiovascular morbidity and mortality.

Detailed description

The material of this retrospective study consist patients without preoperative history of atrial fibrillation, participated in three different randomized controlled trials previously . A total of 519 consecutive patients underwent coronary artery bypass surgery, aortic valve replacement or combined aortic valve with coronary bypass surgery in Kuopio University Hospital from 2004 to 2008. Patients with previous episodes of atrial fibrillation (AF) or flutter and also patients with mitral valve surgery were excluded. All patients had continuous postoperative ECG monitoring for at least 48 hours. AF episodes lasting longer than 5 minutes were registered. Thereafter 12 lead ECG was recorded daily and in case of symptoms of rhythm disturbances. Medical records were reviewed during 2012 using standardized data collection protocol. Statistics Finland database was used for mortality data.

Interventions

None listed

Sponsors

University of Eastern Finland
CollaboratorOTHER
Kuopio University Hospital
Lead SponsorOTHER

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* previously cardiac operation, CABG or AVR

Exclusion criteria

* Previous Atrial fibrillation

Design outcomes

Primary

MeasureTime frame
cardiovascular and all-cause death1-105 month
stroke1-105 month
late atrial fibrillation1-105 month
myocardial infarction1-105 month

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026